ArticleFrontiers in oncology2024
A clinical study of minimal blood flow clamping combined with 3D printing technology in laparoscopic nephron-sparing surgery.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Personalized sports recommendation systems using robotic-assisted techniques in urologic oncology recovery.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the safety and effectiveness of minimum flow clamping combined with 3D printing technology and highly selective renal artery clamping in laparoscopic nephron-sparing surgery. Methods: Fifty-two patients with renal cancer undergoing partial resection admitted to Luoyang Central Hospital Affiliated with Zhengzhou University from 2018-01 to 2021-12 were randomly divided into two groups. Group A comprised 30 cases that underwent laparoscopic partial nephrectomy by minimal blood flow clamping combined with 3D printing technology. Group B comprised 22 cases that underwent laparoscopic partial nephrectomy by highly selective renal artery clamping technology. The operation time, renal artery branch clamping time, intraoperative blood loss, postoperative renal function injury, and complication rate were compared between the two groups. Results: The operation time, blood loss, renal function injury, and complication rate of Group A were shorter than those of Group B (p < 0.05). The time of renal artery clamping in Group B was shorter than that in Group A (p < 0.05). There was no statistical significance in the positive rate of resection margin between the two groups (p > 0.05). Conclusions: In laparoscopic nephron-sparing surgery, minimum blood flow clamping technology not only can meet the requirements of accurate tumor resection but also can maximize the preservation of residual renal function, greatly shorten the operation time, reduce the amount of blood loss, and reduce the incidence of perioperative complications, making it worthy of promotion in clinical work. Clinical Trial Registration: [website], identifier [registration number].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.